Table 3.
Screening and prostate cancer (PC) mortality outcomes in the projected population (N=10,000) when PCA3 varies by grade, for select strategies from Table 2. Grade-specific sensitivities refer to the PCA3 test properties alone. Grade is either low grade (LG) or moderate to high-grade (M-HG).
Strategy | LG Median PCA3 | M-HG Median PCA3 | LG Sensitivity of PCA3 | M-HG Sensitivity of PCA3 | LG Cases Detected | M-HG Cases Detected | Over-diagnoses | PC Deaths | Lives Saved |
---|---|---|---|---|---|---|---|---|---|
PSA(4)+PCA3(20) | 50 | 50 | 0.758 | 0.758 | 531 | 389 | 291 | 223 | 130 |
30 | 85 | 0.630 | 0.850 | 443 | 437 | 272 | 223 | 130 | |
20 | 103 | 0.500 | 0.874 | 353 | 449 | 241 | 228 | 125 | |
PSA(4)+ PCA3(35) | 50 | 50 | 0.616 | 0.616 | 431 | 316 | 237 | 247 | 105 |
30 | 85 | 0.445 | 0.752 | 312 | 386 | 211 | 246 | 107 | |
20 | 103 | 0.297 | 0.790 | 211 | 406 | 178 | 250 | 103 |